Clinical trial
CRP/ Albumin Ratio and Neutrophil Lymphocyte Ratio in Predicting Activity in IBD Patients
NCT06750315 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CRP/ Albumin Ratio and Neutrophil Lymphocyte Ratio in Predicting Activity in IBD Patients
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 1, 2025
- Completion date
- December 1, 2025
- Enrollment
- 35 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory bowel disease (ibd)